Diabetic Neuropathy is a very common illness that has a significant impact on patients by raising the risk of falls, causing discomfort, and lowering quality of life (QOL). In the US, the annual cost of diabetic neuropathy and associated complications exceeds $10 billion. Many research have evaluated the incidence and/or prevalence of neuropathy, albeit each study's definition of neuropathy is unique. According to two population-based studies using door-to-door screening, neuropathy prevalence ranges between 1% and 4%, with diabetes accounting for 40–55% of these cases.
Similar to this, another study found that once a neurologist completed a diagnostic work-up, diabetes was the cause of Diabetic Neuropathy in more than half of cases. The incidence of neuropathy in the Netherlands rises sharply with age, from 50 cases per 100,000 person-years in people under 50 to 300 cases per 100,000 person-years in people over 75, with diabetes accounting for 32% of all cases.
